Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

Cited by (601)

Items 201–300 of 601

1. Hypertension and new treatment approaches targeting the sympathetic nervous system
   Luke Joseph Laffin, George L. Bakris · 2014 · Current Opinion in Pharmacology
2. Vagal Modulation of Hypertension
   Bradley Petkovich, Joshua Vega, Sabu Thomas · 2015 · Current Hypertension Reports
3. The Year in Heart Failure
   ANJALI TIKU OWENS, Mariell L Jessup · 2012 · Journal of the American College of Cardiology
4. Trained breathing-induced oxygenation acutely reverses cardiovascular autonomic dysfunction in patients with type 2 diabetes and renal disease
   Pasquale B. Esposito, Roberto Mereu, Giacomo De Barbieri, Teresa Rampino, Alessandro Di Toro, Per‐Henrik Groop, Antonio Dal Canton, Luciano Bernardi · 2015 · Acta Diabetologica
5. Baroreflex sensitivity and heart rate variability are predictors of mortality in patients with aneurysmal subarachnoid haemorrhage
   Agnieszka Uryga, Małgorzata Burzyńska, Paweł Tabakow, Magdalena Kasprowicz, Karol P. Budohoski, Agnieszka Kazimierska, Peter S. Smielewski, Marek Czosnyka, Waldemar Goździk · 2018 · Journal of the Neurological Sciences
6. Carotid sinus nerve stimulation attenuates alveolar bone loss and inflammation in experimental periodontitis
   Aline Barbosa Ribeiro, Fernanda Brognara, Josiane Fernandes da Silva, Jaci Airton Castania, Patrícia Garani Fernandes, Rita C. Tostes, Hélio César Salgado · 2020 · Scientific Reports
7. Adhesive nonfibrotic bioelectronic interfaces on diverse peripheral nerves for long-term functional neuromodulation
   Hyunmin Moon, Bastien F.G. Aymon, Jue Deng, Tao Zhou, Vincent Prevosto, Fan Wang, Jingjing Wu, Xuanhe Zhao · 2025 · Science Advances
8. Baroreflex activation therapy in patients with end-stage renal failure
   Joachim Beige, Michael Johann Koziolek, G. Hennig, Amir Hamza, Ralph T. Wendt, Gerhard Anton Muller, Manuel Wallbach · 2015 · Journal of Hypertension
9. Baroreflex activation therapy systems: current status and future prospects
   Gino Seravalle, Raffaella Dell’Oro, Guido M. Grassi · 2019 · Expert Review of Medical Devices
10. Current and future use of neuromodulation in heart failure
    David Duncker, Johann K Bauersachs · 2022 · European Heart Journal Supplements
11. The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study*
    Daniel Gordin, Fadl Elmula M. Fadl Elmula, Bert Andersson, Anders Gottsäter, Johan L. Elf, Thomas Kahan, Kent Lodberg Christensen, Pirkka Vikatmaa, Leena Vikatmaa, Thomas Bastholm Olesen et al. · 2017 · Blood Pressure
12. Device-Based Approaches for the Treatment of Arterial Hypertension
    Jens Jordan · 2017 · Current Hypertension Reports
13. Low-intensity focused ultrasound stimulation treatment decreases blood pressure in spontaneously hypertensive rats
    Dapeng Li, Zhiwei Cui, Shanshan Xu, Tianqi Xu, Shan Wu, Ayache Bouakaz, Mingxi Wan, Siyuan Zhang · 2020 · IEEE Transactions on Biomedical Engineering
14. Dopamine β hydroxylase as a potential drug target to combat hypertension
    Sanjay Kumar Dey, Manisha Saini, Pankaj Prabhakar, Suman Kundu · 2020 · Expert Opinion on Investigational Drugs
15. Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension
    Lisa Amalie Gottlieb, Felix Mahfoud, Stavros Stavrakis, Thomas Jespersen, Dominik Linz · 2024 · Hypertension
16. The brain–heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation
    Valerie Y. H. van Weperen, Marmar Vaseghi · 2025 · Nature reviews. Neuroscience
17. Novedades en hipertensión arterial y diabetes mellitus
    Alberto Cordero, Iñaki Lekuona, Enrique Galve, Pilar Mazón · 2012 · Revista Española de Cardiología
18. Regulation of the sympathetic nervous system by the kidney
    Robyn N. Larsen, Alicia Ann Thorp, Markus Peter Schlaich · 2013 · Current Opinion in Nephrology & Hypertension
19. Renal denervation for treatment-resistant hypertension
    Sebastian Charles Mafeld, Nikhil Vasdev, Philip J. Haslam · 2012 · Therapeutic Advances in Cardiovascular Disease
20. Haemodynamic Responses to Selective Vagal Nerve Stimulation under Enalapril Medication in Rats
    Mortimer Gierthmuehlen, Thomas Stieglitz, Josef Zentner, Dennis T. T. Plachta · 2016 · PLoS ONE
21. Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
    Manish Saxena, T. Shour, Mussadiq Shah, C. B. Wolff, Peter O.O. Julu, Vikas Kapil, David Collier, Fu Liang Ng, Ajay Kumar Gupta, Armida Balawon et al. · 2018 · Journal of the American Heart Association
22. Implant-Mediated Therapy of Arterial Hypertension
    Mortimer Gierthmuehlen, Dennis T. T. Plachta, Josef Zentner · 2020 · Current Hypertension Reports
23. The Sympathetic Nervous System as a Target for the Treatment of Hypertension and Cardiometabolic Diseases
    Steve Sorota · 2013 · Journal of Cardiovascular Pharmacology
24. Proceedings from Duke Resistant Hypertension Think Tank
    Sreekanth Vemulapalli, Jamy D. Ard, George L. Bakris, Deepak L. Bhatt, Alan S. Brown, William C. Cushman, Keith C. Ferdinand, John M. Flack, Jerome L. Fleg, Barry T. Katzen et al. · 2014 · American Heart Journal
25. Resistant Hypertension
    Raymond R. Townsend, Murray Epstein · 2016 · Hypertension
26. Carotid Baroreceptor Stimulation: A Potential Solution for Resistant Hypertension
    Jun Zhang, Shuyu Zhou, Gelin Xu · 2013 · Interventional Neurology
27. Secondary Hypertension, Issues in Diagnosis and Treatment
    Raghavesh Pullalarevu, Ghulam Akbar, Geoffrey S. Teehan · 2014 · Primary Care Clinics in Office Practice
28. Baroreceptor stimulation for resistant hypertension: First implantation in France and literature review
    Pierre‐Yves Courand, Patrick Feugier, S. Workineh, Brahim Harbaoui, Giampiero Bricca, Pierre Lantelme · 2014 · Archives of cardiovascular diseases
29. Baroreceptor Stimulation for Resistant Hypertension
    Ayhan Yoruk, John D. Bisognano, John P. Gassler · 2016 · American Journal of Hypertension
30. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited
    Guang-Ming Tam, Bryan P. Yan, Sharad V. Shetty, Yat‐Yin Lam · 2012 · International Journal of Cardiology
31. Cardioprotective effects of low-level carotid baroreceptor stimulation against myocardial ischemia-reperfusion injury in canine model
    Xia Sheng, Mingxian Chen, Bing S Huang, Jia Liu, Liping Zhou, Mingwei Bao, Shuyan Li · 2016 · Journal of Interventional Cardiac Electrophysiology
32. Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension
    Thierry H. Le Jemtel, William Richardson, Rohan Samson, Abhishek Jaiswal, Suzanne Oparil · 2017 · Current Hypertension Reports
33. Reduced Renal Mass, Salt-Sensitive Hypertension Is Resistant to Renal Denervation
    Ionuț Tudorancea, Thomas E. Lohmeier, Barbara T. Alexander, Dragoș Pieptu, Dragomir Nicolae Șerban, Radu Iliescu · 2018 · Frontiers in Physiology
34. Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension
    Manuel Wallbach, Petra Zürbig, Hassan Dihazi, Gerhard Anton Muller, Rolf Wachter, Joachim Beige, Michael Johann Koziolek, Harald Mischak · 2018 · Journal of Clinical Hypertension
35. Difficulty in initiating sleep is associated with poor morning cardiovascular function
    Hsin-Jung Tsai, Terry B.J. Kuo, Albert C. Yang, Shih‐Jen Tsai, Cheryl C.H. Yang · 2020 · Psychiatry Research
36. Low intensity stimulation of aortic baroreceptor afferent fibers as a potential therapeutic alternative for hypertension treatment
    Ibrahim Muhammad Salman, Omar Ziad Ameer, Sheridan McMurray, Sarah F. Hassan, Arun Sridhar, Stephen J. Lewis, Yee‐Hsee Hsieh · 2022 · Scientific Reports
37. Epidemiology, Prognosis, and Treatment of Resistant Hypertension
    Steven M. Smith · 2013 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
38. Current technologies: an introduction
    Joost Daemen · 2013 · EuroIntervention
39. Renal denervation in treatment-resistant hypertension: a reappraisal
    Alexandre Persu, Yu Jin, Fadl Elmula M. Fadl Elmula, Jean P. Renkin, Aud Høieggen, Sverre Erik Kjeldsen, Jan A. Staessen · 2015 · Current Opinion in Pharmacology
40. Resistant hypertension: baroreflex stimulation as a new tool
    Jan Menne, Jens Jordan, Silvia Linnenweber-Held, Hermann G. Haller · 2012 · Nephrology Dialysis Transplantation
41. Current Therapeutic Approach in Heart Failure with Preserved Ejection Fraction
    Jose N. Nativi-Nicolau, John Jake Ryan, James C. Fang · 2014 · Heart Failure Clinics
42. ASH Scientific Statement Detection, evaluation, and treatment of severe and resistant hypertension Proceedings from an American Society of Hypertension Interactive Forum held in Bethesda, MD, USA, October 10th 2013
    William B. White, John D. Bisognano, David A. Calhoun, Raymond R. Townsend, Herbert D. Aronow, Deepak L. Bhatt, George L. Bakris · 2014
43. The ability of baroreflex activation to improve blood pressure and resistance vessel function in spontaneously hypertensive rats is dependent on stimulation parameters
    Gean Domingos-Souza, Fernanda Machado Santos‐Almeida, César A. Meschiari, Nathanne Santos Ferreira, Camila A. Pereira, Nayara Pestana‐Oliveira, Thaís Caroline Prates-Costa, Rita C. Tostes, Carl White, Rubens Fazan · 2021 · Hypertension Research
44. Electrical carotid baroreceptor stimulation
    Jürg Schmidli, Regula S. von Allmen, Markus Georg Mohaupt · 2014 · Wiener Medizinische Wochenschrift
45. Sympathetic Activation in Resistant Hypertension: Theory and Therapy
    Raymond Oliva, George L. Bakris · 2014 · Seminars in Nephrology
46. Smart Baroreceptor Activation Therapy Strikingly Attenuates Blood Pressure Variability in Hypertensive Rats With Impaired Baroreceptor
    Takeshi Tohyama, Kazuya Hosokawa, Keita Saku, Yasuhiro Oga, Hiroyuki Tsutsui, Kenji Sunagawa · 2019 · Hypertension
47. Barorezeptorakivierungstherapie bei therapierefraktärer Hypertonie: Indikation und Patientenselektion
    Michael Johann Koziolek, Joachim Beige, Manuel Wallbach, Dieter Zenker, G. Henning, Marcel Halbach, Navid Mader, Felix Mahfoud, Georg Schlieper, Vedat Schwenger et al. · 2017 · Der Internist
48. Long-Term Hemodynamic Effects After Carotid Artery Revascularization
    Sungho Lim, Michael J. Javorski, Sean P. Nassoiy, Yaeji Park, Pegge M. Halandras, Carlos Fares Bechara, Bernadette Aulivola, Paul R. Crisostomo · 2019 · Vascular and Endovascular Surgery
49. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials
    Mohammad Ahmed, Matthew S. Nudy, Rahul Bussa, Frank Weigel, Gerald V. Naccarelli, Ankit Maheshwari · 2022 · Trends in Cardiovascular Medicine
50. The Baroreceptor as a Therapeutic Target for Heart Failure
    Edoardo Gronda, Eric G. Lovett, Michela Tarascio, Dimitrios Georgakopoulos, Guido M. Grassi, Emilio Vanoli · 2014 · Journal of Cardiovascular Translational Research
51. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
    Esther de Beus, Nicolette G.C. van der Sande, Michiel L. Bots, Wilko Spiering, Michiel Voskuil, Frank L.J. Visseren, Peter J. Blankestijn · 2017 · BMJ Open
52. Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance
    Àngels Sierra, David A. Calhoun, Ernest Vinyoles, José R. Banegas, Juan J. de la Cruz, Manuel Gorostidi, J. Segura, Luis Miguel Ruilope · 2014 · Journal of Human Hypertension
53. Effects of Baroreflex Activation Therapy on Cardiac Function and Morphology
    Ann-Kathrin C. Schäfer, Manuel Wallbach, Charlotte Schroer, Luca-Yves Lehnig, Stephan Lüders, G Hasenfuss, Rolf Wachter, Michael Johann Koziolek · 2024 · ESC Heart Failure
54. Timing and Efficacy of Alternative Methods of Sympathetic Blockade
    Αlexandros Briasoulis, George L. Bakris · 2012 · Current Hypertension Reports
55. Clinical Trial Design in Contemporary Device Studies in Heart Failure: Is There a Gold Standard?
    Paul J. Hauptman, Stephen S. Gottlieb · 2014 · Journal of Cardiac Failure
56. Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era?
    Maria Yaseen, Waleed Hassan, Radwa Awad, Bilal Ashqar, Javier A. Neyra, Tagalie Heister, Omar Malik, Amr A El-Husseini · 2018 · Kidney Diseases
57. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial
    Sripal Bangalore, Rana S. Fayyad, Rachel E. Laskey, David A. DeMicco, PRAKASH C. DEEDWANIA, John B. Kostis, Franz H. Messerli · 2013 · European Heart Journal
58. Device therapy in heart failure with reduced ejection fraction—cardiac resynchronization therapy and more
    David Duncker, Christian Veltmann · 2018 · Herz
59. The Current Status of Devices for the Treatment of Resistant Hypertension
    Michael Kunz, Lucas Lauder, Sebastian Ewen, Michael Böhm, Felix Mahfoud · 2019 · American Journal of Hypertension
60. Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation
    Guido M. Grassi, Gino Seravalle, Gianmaria Brambilla, Michele Bombelli, Raffaella Dell’Oro, Edoardo Gronda, Giuseppe Mancia · 2012 · Current Hypertension Reports
61. Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure
    Gino Seravalle, Guido M. Grassi · 2015 · High Blood Pressure & Cardiovascular Prevention
62. Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis
    Chunbin Wang, Shiquan Fu, Jing Huang · 2018 · Clinical and Experimental Hypertension
63. Relationship Between Baroreflex and Cerebral Autoregulation in Patients With Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
    Agnieszka Uryga, Nathalie Nasr, Magdalena Kasprowicz, Karol P. Budohoski, Marek Sykora, Peter S. Smielewski, Małgorzata Burzyńska, Marek Czosnyka · 2022 · Frontiers in Neurology
64. Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012
    Thomas Weber, Robert Zweiker, Bruno Watschinger, P Grüner, Christian Koppelstätter, Mathias Christoph Brandt, Jörg H. Horina, Helmut Brussee, Katharina Hohenstein, Thomas Lambert et al. · 2012 · Wiener klinische Wochenschrift
65. Renal denervation: Alternative treatment options for hypertension?
    Aashish Anand Gupta, Marloe Prince, Tamunoinemi Bob‐Manuel, James Stephen Jenkins · 2019 · Progress in Cardiovascular Diseases
66. Device-Based Therapy for Drug-Resistant Hypertension: An Update
    Ping Li, Mark Abi Nader, K Arunagiri, Vasilios Papademetriou · 2016 · Current Hypertension Reports
67. Interaction between baroreflex and chemoreflex in the cardiorespiratory responses to stimulation of the carotid sinus/nerve in conscious rats
    Pedro L. Katayama, Jaci Ayrton Castania, Rubens Fazan, Hélio César Salgado · 2018 · Autonomic Neuroscience
68. 2018 ESC/ESH guidelines about new methods of treatment of hypertension — “DEVICE-BASED TREATMENT”
    Tatiana M. Ripp, Victor F. Mordovin · 2019 · Arterial’naya Gipertenziya (Arterial Hypertension)
69. Low‐Level Tragus Stimulation Attenuates Blood Pressure in Young Individuals With Hypertension: Results From a Small‐Scale Single‐Blind Controlled Randomized Clinical Trial
    Muisha B. Mbikyo, Wang Ai, Qun Ma, Linlin Miao, Nan Cui, Yiqing Yang, Haoran Fu, Yingxian Sun, Zhao Li · 2024 · Journal of the American Heart Association
70. Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!
    Giuseppe Maiolino, Matteo Azzolini, Gian Paolo Rossi · 2015 · Frontiers in Cardiovascular Medicine
71. Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension
    Marcel Halbach, David Grothaus, Fabian Hoffmann, Navid Madershahian, Kathrin Kuhr, Hannes Reuter · 2020 · Clinical Autonomic Research
72. Electrical Carotid Sinus Stimulation: Chances and Challenges in the Management of Treatment Resistant Arterial Hypertension
    Kristine Chobanyan-Jürgens, Jens Jordan · 2015 · Current Hypertension Reports
73. Cardiovascular responses elicited by continuous versus intermittent electrical stimulation of the aortic depressor nerve in conscious rats
    Fernanda Brognara, Daniel Penteado Martins Dias, Jaci Ayrton Castania, Rubens Fazan, Stephen J. Lewis, Hélio César Salgado · 2016 · Life Sciences
74. Resistant Hypertension in Diabetes Mellitus
    Pedro Armario · 2015 · Journal of Endocrinology and Diabetes
75. Carotid baroreceptor stimulation blood pressure response mapped in patients undergoing carotid endarterectomy (C-Map study)
    Nikhil Kansal, Daniel G. Clair, Deborah A. Jaye, Avram Scheiner · 2016 · Autonomic Neuroscience
76. The effect of renal denervation in an experimental model of chronic renal insufficiency, The REmnant kidney Denervation In Pigs study (REDIP study)
    Jean-Claude Lubanda, Miroslav Chochola, Mikuláš Mlček, Petr Neužil, Josef J. Marek, Štěpán Havránek, Sylvie Kuchynková, Zdeňka Fingrová, Kao-Hsuan Aimee Huang, Aleš Linhart · 2017 · Journal of Translational Medicine
77. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients
    James Arthur Mann, William T. Abraham · 2019 · Current Heart Failure Reports
78. Treatment-resistant hypertension assessed by home blood pressure monitoring: a new target for intervention?
    Michiaki Nagai, Keigo Dote · 2021 · Hypertension Research
79. Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases
    Le Li, Zhao Y. Hu, Yulong Xiong, Yan Yao · 2021 · Frontiers in Cardiovascular Medicine
80. Recent Clinical Trials of Hypertension Management
    Garry Jennings · 2013 · Hypertension
81. New Drugs and Devices in the Pipeline for Heart Failure with Reduced Ejection Fraction Versus Heart Failure with Preserved Ejection Fraction
    Amresh Raina, Manreet Kaur Kanwar · 2014 · Current Heart Failure Reports
82. Closed-Loop Neuromodulation Technology for Baroreflex Blood Pressure Control
    Kazuya Hosokawa, Kenji Sunagawa · 2015 · Proceedings of the IEEE
83. Rescue baroreflex activation therapy after Stanford B aortic dissection due to therapy-refractory hypertension
    Kay F. Weipert, Astrid Kerstin Most, Oliver Dörr, Inga Helmig, Meshal Elzien, Gabriele Anja Krombach, Christian W. Hamm, Damir Erkapic, Joern Schmitt · 2016 · Journal of the American Society of Hypertension
84. Baroreflex deficiency aggravates atherosclerosis via α7 nicotinic acetylcholine receptor in mice
    Li Chen, Dian‐Hua Liu, Xin Zhang, En-Hui Zhang, Chong Liu, Ding‐Feng Su, Guojun Cai · 2016 · Vascular Pharmacology
85. Resistant hypertension
    Fang‐Fei Wei, Zhen‐Yu Zhang, Qi‐Fang Huang, Wen‐Yi Yang, Jan A. Staessen · 2018 · Kardiologia Polska
86. Does treatment-resistant hypertension exist in children? A review of the evidence
    Ian R. Macumber, Joseph T. Flynn · 2019 · Pediatric Nephrology
87. Interventional Approaches to Reduce Sympathetic Activity in Resistant Hypertension: To Ablate or Stimulate?
    Biaggioni, Italo · 2012 · Hypertension
88. Interventional hypertension
    Vito M. Campese · 2013 · Journal of Hypertension
89. Neuromodulation Therapies in Heart Failure: A State-of-the-Art Review
    Mohit Pahuja, Khawaja Hassan Akhtar, Satyam Krishan, YUSRA MINAHIL NASIR, Philippe Généreux, Stavros Stavrakis, Tarun W. Dasari · 2023 · Journal of the Society for Cardiovascular Angiography & Interventions
90. Real-time closed-loop brainstem stimulation modality for enhancing temporal blood pressure reduction
    Junseung Mun, Jiho Lee, Sung‐Min Park · 2024 · Brain stimulation
91. Hypertension and Device-Based Therapies for Resistant Hypertension: An Up-to-Date Review
    Oluwaremilekun Zeth Tolu-Akinnawo, David N Ray, Tiwalade Awosanya, Chike Magnus Nzerue, Henry T. Okafor · 2024 · Cureus
92. Recent Advancements in the Treatment of Resistant Hypertension
    Donald Clark, Jason L. Guichard, David A. Calhoun, Mustafa I. Ahmed · 2012 · Postgraduate Medicine
93. Device-Based Therapy for Resistant Hypertension: An Up‐to‐Date Review
    Oussama Jami, Youssef Tijani, Aziz Ettahir · 2022 · High Blood Pressure & Cardiovascular Prevention
94. Research needs in the area of device-related treatments for hypertension
    Jens Jordan, Johannes F.E. Mann, Friedrich Cameron Luft · 2013 · Kidney International
95. Update in Hypertension Therapy
    Leonard A. Mankin · 2016 · Medical Clinics of North America
96. A systematic review and meta-analysis of all sham and placebo controlled trials for resistant hypertension
    Mohammad Ahmed, Matthew S. Nudy, Rahul Bussa, Edward John Filippone, Andrew Foy · 2023 · European Journal of Internal Medicine
97. Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis
    Annalisa Biffi, Fosca Quarti‐Trevano, Jennifer Vanoli, Raffaella Dell’Oro, Giovanni Corrao, Giuseppe Mancia, Guido M. Grassi · 2024 · Hypertension Research
98. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction
    Marcel Halbach, Tilman Hickethier, Navid Madershahian, Jochen Müller‐Ehmsen · 2014 · Expert Review of Cardiovascular Therapy
99. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?
    Sreekanth Vemulapalli, Crystal C. Tyson, Laura P. Svetkey · 2014 · Advances in Chronic Kidney Disease
100. Baroreflex activation therapy for patients with drug-resistant hypertension
     Teba Alnima, Abraham A. Kroon, Peter W. de Leeuw · 2014 · Expert Review of Cardiovascular Therapy